Da Vita Clinical Research is categorized under Kidney Dialysis Centers in Minneapolis, MN .
Da Vita Clinical Research was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214920 by the NAICS.
If you are seeking more information, feel free to contact Harry Alcorn, Partner at the company’s single location by writing to 825 South 8th St # 300, Minneapolis, Minnesota MN 55404 or by phoning (612) 852-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Da Vita Clinical Research |
| Contact Person: | Harry Alcorn, Partner |
| Address: | 825 South 8th St # 300, Minneapolis, Minnesota 55404 |
| Phone Number: | (612) 852-7000 |
| Website Address: | davitaclinicalresearch.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 6214920 |
| Share This Business: |
Da Vita Clinical Research was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Harry Alcorn, Partner for inquiries that concern Da Vita Clinical Research by calling the company number (612) 852-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Da Vita Clinical Research can be found at the coordinates 44.97083,-93.26118 as well as the street address 825 South 8th St # 300 in Minneapolis, Minnesota 55404.
For its online presence, you may visit Da Vita Clinical Research’s website at davitaclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.